To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
17 Current newsrss
uniQure B.V. announced a non-exclusive cross-licensing agreement with Benitec Biopharma Ltd. giving uniQure access to Benitec’s proprietary DNA-directed RNA interference (ddRNAi) technology...
Benitec Ltd announced that two further patents owned or licensed exclusively by Benitec have been granted or allowed in Europe and the US respectively.The CSIRO-owned patent EP1068311-B1 (“Methods...
Benitec Limited announced that following the success of the first stage of its anti-viral program to develop an RNA interference (RNAi)-based therapy against Hepatitis B virus (HBV), conducted...
Graham ‘099 Patent Re-Examination Certificate Issued in the US and another Graham Patent granted in a Further European Country
Benitec Limited announced that the United States Patent and Trademark Office (USPTO) has indicated that it is issuing the Re-examination Certificate, the formal final step in the USPTO’s confirmation...
Collaboration with City of Hope in HIV trial
Benitec Limited has secured further intellectual property rights that underpin its HIV/AIDS lymphoma therapeutic currently undergoing clinical trials at City of Hope in Duarte, California...
, Benitec and Oxford BioMedica provide Sigma-Aldrich with a major intellectual property portfolio in RNAi. Existing members of the Sigma RNAi Partnership Program include Rutgers University, University...
Benitec Ltd. announced that the Investigational New Drug (IND) filing with the US Food & Drug Administration (FDA) for its HIV/AIDS therapeutic will be delayed. The delay is due to one aberrant...
Sigma-Aldrich Acquires Equity Stake in Benitec
Benitec Ltd. and Sigma-Aldrich Corporation announced the signing of two major agreements, one in which Sigma acquires an equity stake in Benitec and one in which Benitec grants Sigma a license...